TROY, NY – St. Peter's Health Partners has been selected to partner with the American Cancer Society in the largest cancer prevention study ever conducted in the United States.
Cancer Prevention Study-3, or CPS-3, is a long-term epidemiology study planned for the next 20-30 years. It will involve more than 300,000 people of various racial and ethnic backgrounds recruited nationwide.
SPHP hopes to recruit more than 800 volunteers through its four hospitals in the Capital Region, including St. Peter's Hospital and Albany Memorial Hospital in Albany; Samaritan Hospital and St. Mary's Hospital in Troy; and The Eddy network of services. Men and women between the ages of 30-65 years old who have never been diagnosed with cancer are eligible to enroll. Basal or squamous cell skin cancer diagnoses will not disqualify a volunteer from participating.
"We all know someone a loved one or a friend – whose life has been touched by cancer," James K. Reed, MD, president and chief executive officer of St. Peter's Health Partners, said. "This is a historic study, and a once-in-a-lifetime opportunity to be a part of what is potentially life-saving research."
"More than 11 million people have survived cancer, so as the largest health system in the Capital Region, we are proud to be selected to partner in what will be the next wave of cancer prevention and cancer solutions," he added. "By enrolling to become a participant, all of us are helping to protect our future generations – our children and grandchildren – from ever developing this horrible disease."
More than 300 scientific articles have already been published from previous American Cancer Society studies. These studies have demonstrated vital findings that significantly impact our health, including the link between cigarette smoking and lung cancer; the role of being overweight or obese on the risk of cancer occurrence and death; the link of physical activity and lower risk of various cancers (including breast, colon and prostate cancers); and the impact of hormones, diet, various medications and vitamins, and a variety of other factors in relation to cancer risk.
Enrollment of participants for the CPS-3 study launched on December 6, 2006 and will close on December 6, 2013. Such new follow-up studies are needed as the current study population ages and environmental and individual lifestyles change over time. Enrollees will be asked to complete follow-up surveys at home every few years for the next 20-30 years to help researchers build on evidence from earlier studies, and better understand the lifestyle, environmental and genetic factors that cause or prevent cancer.
Enrollment sessions will be held at two SPHP locations: Wednesday, Dec. 4 from 11:30 a.m. – 5:30 p.m. at St. Peter's Hospital and Friday, Dec. 6 from 10:30 a.m. – 3:30 p.m. at Samaritan Hospital.
Appointment times can be scheduled online at www.cps3AlbanyTroy.org.
Participants will be asked to sign a consent form and complete a brief survey, waist circumference will be recorded and a small blood sample will also be drawn. All information will be kept confidential.
For more information, call St. Peter's Cancer Care Line at (518) 525-1547.
341 Northern Blvd., Albany, NY 12204
Can’t find something?
All content © Copyright 2000 - 2014 Young Broadcasting of Albany, Inc. A Media General Company.